Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Food Hypersensitivity | 1 | 2019 | 397 | 0.52 | Why? |
| Benchmarking | 1 | 2017 | 627 | 0.50 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.46 | Why? |
| Orthomyxoviridae Infections | 1 | 2017 | 1001 | 0.41 | Why? |
| Influenza A virus | 2 | 2017 | 2234 | 0.36 | Why? |
| Influenza A Virus, H5N2 Subtype | 2 | 2017 | 15 | 0.36 | Why? |
| Genome, Viral | 5 | 2020 | 13157 | 0.32 | Why? |
| Computational Biology | 2 | 2019 | 4514 | 0.30 | Why? |
| Transcriptome | 2 | 2018 | 3466 | 0.29 | Why? |
| Neuraminidase | 2 | 2018 | 289 | 0.29 | Why? |
| Host-Pathogen Interactions | 4 | 2017 | 11041 | 0.28 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2019 | 572 | 0.27 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.26 | Why? |
| Influenza A Virus, H1N1 Subtype | 4 | 2019 | 2984 | 0.26 | Why? |
| Influenza, Human | 8 | 2021 | 10779 | 0.26 | Why? |
| Proteome | 1 | 2012 | 1812 | 0.23 | Why? |
| Influenza B virus | 2 | 2018 | 815 | 0.22 | Why? |
| Proteomics | 1 | 2012 | 2481 | 0.22 | Why? |
| Orthomyxoviridae | 2 | 2018 | 1168 | 0.20 | Why? |
| Chromosome Mapping | 1 | 2020 | 178 | 0.20 | Why? |
| RNA, Guide | 1 | 2021 | 269 | 0.20 | Why? |
| Retinal Neurons | 1 | 2018 | 7 | 0.19 | Why? |
| Intermediate Filament Proteins | 1 | 2018 | 9 | 0.19 | Why? |
| Zinc Finger Nucleases | 1 | 2018 | 1 | 0.19 | Why? |
| Giant Cells | 1 | 2021 | 334 | 0.18 | Why? |
| Gene Deletion | 1 | 2020 | 430 | 0.18 | Why? |
| Antigenic Variation | 1 | 2018 | 249 | 0.17 | Why? |
| Cyclohexanes | 1 | 2017 | 43 | 0.17 | Why? |
| Medical History Taking | 1 | 2020 | 350 | 0.17 | Why? |
| Deoxycytidine | 1 | 2018 | 116 | 0.17 | Why? |
| Influenza A Virus, H9N2 Subtype | 1 | 2017 | 61 | 0.17 | Why? |
| Transgenes | 1 | 2018 | 227 | 0.16 | Why? |
| Singapore | 7 | 2021 | 3641 | 0.16 | Why? |
| Sequence Alignment | 2 | 2020 | 2109 | 0.16 | Why? |
| Open Reading Frames | 2 | 2020 | 1898 | 0.16 | Why? |
| Receptors, CCR5 | 1 | 2017 | 186 | 0.15 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.15 | Why? |
| Population Density | 1 | 2021 | 694 | 0.15 | Why? |
| Terminology as Topic | 1 | 2021 | 546 | 0.15 | Why? |
| Gene Ontology | 1 | 2017 | 391 | 0.15 | Why? |
| Genetic Engineering | 1 | 2018 | 325 | 0.15 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.15 | Why? |
| Umbilical Cord | 1 | 2018 | 358 | 0.15 | Why? |
| Thailand | 1 | 2020 | 1155 | 0.15 | Why? |
| Databases, Protein | 1 | 2019 | 523 | 0.14 | Why? |
| Retinal Vessels | 1 | 2018 | 255 | 0.14 | Why? |
| Leprosy | 1 | 2017 | 142 | 0.14 | Why? |
| Drug Resistance, Viral | 2 | 2018 | 1083 | 0.14 | Why? |
| Gene Editing | 1 | 2018 | 330 | 0.14 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 386 | 0.13 | Why? |
| Dogs | 2 | 2019 | 2529 | 0.13 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.13 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.13 | Why? |
| Allergens | 1 | 2019 | 728 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Amino Acid Sequence | 3 | 2020 | 6049 | 0.12 | Why? |
| Influenza in Birds | 1 | 2017 | 528 | 0.12 | Why? |
| Chickens | 1 | 2017 | 1010 | 0.11 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.11 | Why? |
| Proteins | 1 | 2019 | 921 | 0.11 | Why? |
| Mutation | 4 | 2021 | 12376 | 0.11 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.10 | Why? |
| Dermatitis, Atopic | 1 | 2018 | 714 | 0.10 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.09 | Why? |
| Viral Proteins | 2 | 2017 | 7370 | 0.09 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Enzyme Inhibitors | 1 | 2018 | 1881 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.08 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.08 | Why? |
| Disease Reservoirs | 1 | 2016 | 1672 | 0.08 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.08 | Why? |
| Mass Spectrometry | 1 | 2012 | 1165 | 0.08 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.08 | Why? |
| Bacterial Proteins | 2 | 2021 | 1318 | 0.08 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.07 | Why? |
| Animals | 8 | 2021 | 78931 | 0.07 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.07 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Cell Line | 2 | 2017 | 12040 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Humans | 28 | 2021 | 930598 | 0.07 | Why? |
| Travel | 2 | 2020 | 7220 | 0.07 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.06 | Why? |
| Gene Frequency | 2 | 2018 | 1210 | 0.06 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| Spatio-Temporal Analysis | 2 | 2020 | 1182 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Base Sequence | 2 | 2020 | 3581 | 0.06 | Why? |
| World Health Organization | 3 | 2021 | 4213 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Chiroptera | 1 | 2016 | 3530 | 0.06 | Why? |
| Amino Acid Substitution | 2 | 2018 | 1706 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| COS Cells | 1 | 2020 | 157 | 0.05 | Why? |
| Antiviral Agents | 3 | 2019 | 41703 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Endodeoxyribonucleases | 1 | 2021 | 149 | 0.05 | Why? |
| Virus Integration | 1 | 2020 | 96 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.05 | Why? |
| Protein Structure, Quaternary | 1 | 2021 | 455 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| CHO Cells | 1 | 2021 | 831 | 0.05 | Why? |
| Prenylation | 1 | 2017 | 3 | 0.05 | Why? |
| Viral Nonstructural Proteins | 1 | 2016 | 4810 | 0.05 | Why? |
| CRISPR-Associated Proteins | 1 | 2021 | 258 | 0.04 | Why? |
| Cricetulus | 1 | 2021 | 936 | 0.04 | Why? |
| Microbial Sensitivity Tests | 2 | 2018 | 2886 | 0.04 | Why? |
| Phantoms, Imaging | 1 | 2018 | 146 | 0.04 | Why? |
| Peptide Library | 1 | 2021 | 564 | 0.04 | Why? |
| Blotting, Western | 1 | 2020 | 863 | 0.04 | Why? |
| Conserved Sequence | 1 | 2020 | 751 | 0.04 | Why? |
| CARD Signaling Adaptor Proteins | 1 | 2017 | 70 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2020 | 835 | 0.04 | Why? |
| Transfection | 1 | 2020 | 864 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2019 | 640 | 0.04 | Why? |
| Diagnostic Techniques, Ophthalmological | 1 | 2018 | 136 | 0.04 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
| Plasmids | 1 | 2020 | 840 | 0.04 | Why? |
| Membrane Fusion | 1 | 2021 | 713 | 0.04 | Why? |
| Herpesviridae | 1 | 2017 | 100 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 624 | 0.04 | Why? |
| Exome | 1 | 2017 | 207 | 0.04 | Why? |
| Phylogeography | 1 | 2020 | 824 | 0.04 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.04 | Why? |
| Ecology | 1 | 2016 | 140 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.04 | Why? |
| China | 2 | 2020 | 50654 | 0.04 | Why? |
| Phagocytosis | 1 | 2017 | 409 | 0.04 | Why? |
| Global Health | 4 | 2021 | 13911 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2017 | 478 | 0.04 | Why? |
| Mice | 3 | 2020 | 21357 | 0.04 | Why? |
| Macrophage Activation | 1 | 2017 | 315 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.04 | Why? |
| Bacteriophages | 1 | 2017 | 268 | 0.03 | Why? |
| Endocytosis | 1 | 2017 | 451 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.03 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.03 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.03 | Why? |
| Urine | 1 | 2016 | 469 | 0.03 | Why? |
| Ferrets | 1 | 2019 | 1201 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2021 | 2372 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Glycosylation | 1 | 2017 | 1255 | 0.03 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.03 | Why? |
| Bangladesh | 1 | 2018 | 1620 | 0.03 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.03 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Adenoviridae | 1 | 2017 | 1151 | 0.03 | Why? |
| Female | 7 | 2021 | 380317 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Biological Evolution | 1 | 2016 | 641 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.03 | Why? |
| Genetic Vectors | 1 | 2018 | 1600 | 0.03 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.03 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.02 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.02 | Why? |
| Models, Molecular | 2 | 2017 | 7616 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.02 | Why? |
| History, 21st Century | 1 | 2016 | 1849 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Frail Elderly | 1 | 2018 | 1427 | 0.02 | Why? |
| Seroconversion | 1 | 2018 | 2515 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Solvents | 1 | 2008 | 139 | 0.02 | Why? |
| Mutant Proteins | 1 | 2008 | 328 | 0.02 | Why? |
| Protein Folding | 1 | 2008 | 270 | 0.02 | Why? |
| Dimerization | 1 | 2008 | 475 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2016 | 3776 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.02 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Hydrogen Bonding | 1 | 2008 | 599 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Male | 7 | 2021 | 367725 | 0.02 | Why? |
| Skin | 1 | 2017 | 2096 | 0.02 | Why? |
| Antibody Formation | 1 | 2018 | 4038 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.02 | Why? |
| Interferons | 1 | 2017 | 2885 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Thermodynamics | 1 | 2008 | 873 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Protein Structure, Secondary | 1 | 2008 | 1077 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Protein Structure, Tertiary | 1 | 2008 | 1565 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Feces | 1 | 2016 | 4235 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Structure-Activity Relationship | 1 | 2008 | 2219 | 0.01 | Why? |
| Databases, Factual | 1 | 2016 | 6248 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Temperature | 1 | 2008 | 2305 | 0.01 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Computer Simulation | 1 | 2008 | 4982 | 0.01 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
Maurer-Stroh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(249)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(215)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_